Home Cart 0 Sign in  
X

[ CAS No. 30683-23-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 30683-23-9
Chemical Structure| 30683-23-9
Chemical Structure| 30683-23-9
Structure of 30683-23-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 30683-23-9 ]

Related Doc. of [ 30683-23-9 ]

Alternatived Products of [ 30683-23-9 ]

Product Details of [ 30683-23-9 ]

CAS No. :30683-23-9 MDL No. :MFCD01320380
Formula : C6H4BrNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KBDIRPOTVAODSA-UHFFFAOYSA-N
M.W : 202.01 Pubchem ID :2050129
Synonyms :

Calculated chemistry of [ 30683-23-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.9
TPSA : 50.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.13
Log Po/w (XLOGP3) : 1.4
Log Po/w (WLOGP) : 1.54
Log Po/w (MLOGP) : -0.34
Log Po/w (SILICOS-IT) : 1.43
Consensus Log Po/w : 1.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.35
Solubility : 0.897 mg/ml ; 0.00444 mol/l
Class : Soluble
Log S (Ali) : -2.06
Solubility : 1.77 mg/ml ; 0.00875 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.26
Solubility : 1.12 mg/ml ; 0.00555 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.37

Safety of [ 30683-23-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 30683-23-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 30683-23-9 ]
  • Downstream synthetic route of [ 30683-23-9 ]

[ 30683-23-9 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 55758-02-6 ]
  • [ 30683-23-9 ]
Reference: [1] Organic Letters, 2008, vol. 10, # 13, p. 2701 - 2704
[2] Patent: US2010/69425, 2010, A1, . Location in patent: Page/Page column 13
  • 2
  • [ 188677-47-6 ]
  • [ 30683-23-9 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 6, p. 1075 - 1086
  • 3
  • [ 10354-53-7 ]
  • [ 30683-23-9 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 6, p. 1075 - 1086
  • 4
  • [ 30683-23-9 ]
  • [ 53636-56-9 ]
YieldReaction ConditionsOperation in experiment
82% With sulfuric acid In methanol at 20℃; for 12 h; a) To the methanol solution of compound 16a (1 g, 4.9 mmol, Matrix) at room temperature was added a few drops of concentrated sulfuric acid. The mixture was stirred for 12 hours. After removal of MeOH, the crude residue was purified on silica gel column on CombiFlash.(R). with 20-50percent EtOAc in hexane to provide compound 16b (450 mg, 41percent). Compound 17 (yield 82percent) was synthesized following the procedure described in Example 1 for preparing compound 4 starting from compound 16b.
Reference: [1] Patent: US2011/136833, 2011, A1, . Location in patent: Page/Page column 27
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 2, p. 635 - 654
[3] Patent: US3963733, 1976, A,
  • 5
  • [ 30683-23-9 ]
  • [ 74-88-4 ]
  • [ 53636-56-9 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With sodium hydride In DMF (N,N-dimethyl-formamide) at 0℃; for 0.833333 h;
Stage #2: at 0 - 20℃; for 48 h;
Sodium hydride (0.238 g of a 60percent dispersion in mineral oil, 5.95 mmol) was added to a stirred solution of 3-bromopyridine-2-carboxylic acid (1.00 g, 4.95 mmol) in DMF (18mL) at 0° C. under nitrogen. The mixture was stirred for 50 min and methyl iodide (0.31 mL, 4.98 mmol) was then added dropwise. The mixture was allowed to warm up gradually to room temperature and was stirred for 2 days. Water was added and the mixture evaporated in vacuo. The residue was partitioned between dichloromethane and water and the aqueous layer separated and re-extracted with dichloromethane (.x.2). The combined organic layers were dried (MgSO4) and evaporated in vacuo and the residue purified by flash chromatography on silica gel, eluting with 80percent ethyl acetate in hexane, to give the title-ester (0.77 g, 72percent), 1H NMR (400 MHz, CDCl3) δ8.62 (1H, dd, J=4.6 and 1.4 Hz), 8.01 (1H, dd, J=8.2 and 1.4 Hz), 7.31 (1H, dd, J=8.2 and 4.6 Hz), 4.02 (3H, s).
Reference: [1] Patent: US2004/6226, 2004, A1, . Location in patent: Page 11
[2] Synthetic Communications, 1997, vol. 27, # 6, p. 1075 - 1086
  • 6
  • [ 67-56-1 ]
  • [ 30683-23-9 ]
  • [ 53636-56-9 ]
YieldReaction ConditionsOperation in experiment
42% Heating / reflux A mixture of 5.45 g of 3-bromo-2-pyridine carboxylic acid (27.0 mmol, 1 eq.), obtained in example 3b), in 100 ml of methanol is reflux heated in the presence of 8 ml of sulfuric acid. The reaction mixture is allowed to return to ambient temperature and poured into water. It is extracted 3 times with ethyl acetate, the organic phase is dried on Na2SO4 and vacuum evaporated. 2.48 g (42percent) of esterified product is obtained. NMR (1H, CDCl3): 4.02 (s; 3H), 7.34 (dd, J=8.2, 2.8 Hz; 1H), 8.04 (d, J=8.2 Hz; 1H), 8.64 (d, J=2.8 Hz; 1H).
Reference: [1] European Journal of Organic Chemistry, 2014, vol. 2014, # 10, p. 2140 - 2149
[2] Patent: US2005/80085, 2005, A1, . Location in patent: Page/Page column 6
[3] Organic Letters, 2008, vol. 10, # 13, p. 2701 - 2704
[4] Patent: WO2010/44054, 2010, A1, . Location in patent: Page/Page column 107
[5] Patent: US2011/230495, 2011, A1, . Location in patent: Page/Page column 18
[6] Patent: US2015/232460, 2015, A1, . Location in patent: Paragraph 0506-0508
[7] Advanced Synthesis and Catalysis, 2016, vol. 358, # 20, p. 3283 - 3292
  • 7
  • [ 30683-23-9 ]
  • [ 52378-64-0 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 11, p. 3310 - 3313
  • 8
  • [ 30683-23-9 ]
  • [ 754131-60-7 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 11, p. 3310 - 3313
  • 9
  • [ 30683-23-9 ]
  • [ 878805-23-3 ]
Reference: [1] Patent: US2015/232460, 2015, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 30683-23-9 ]

Bromides

Chemical Structure| 1211515-68-2

[ 1211515-68-2 ]

3-Bromo-5-methylpicolinic acid

Similarity: 0.94

Chemical Structure| 53636-56-9

[ 53636-56-9 ]

Methyl 3-bromo-2-pyridinecarboxylate

Similarity: 0.91

Chemical Structure| 61830-40-8

[ 61830-40-8 ]

3,5-Dibromopicolinic acid

Similarity: 0.91

Chemical Structure| 1133116-49-0

[ 1133116-49-0 ]

3,6-Dibromopicolinic acid

Similarity: 0.91

Chemical Structure| 1033201-61-4

[ 1033201-61-4 ]

6-Amino-3-bromopicolinic acid

Similarity: 0.91

Carboxylic Acids

Chemical Structure| 1211515-68-2

[ 1211515-68-2 ]

3-Bromo-5-methylpicolinic acid

Similarity: 0.94

Chemical Structure| 61830-40-8

[ 61830-40-8 ]

3,5-Dibromopicolinic acid

Similarity: 0.91

Chemical Structure| 1133116-49-0

[ 1133116-49-0 ]

3,6-Dibromopicolinic acid

Similarity: 0.91

Chemical Structure| 1033201-61-4

[ 1033201-61-4 ]

6-Amino-3-bromopicolinic acid

Similarity: 0.91

Chemical Structure| 1189513-50-5

[ 1189513-50-5 ]

3-Bromo-5-chloropicolinic acid

Similarity: 0.86

Related Parent Nucleus of
[ 30683-23-9 ]

Pyridines

Chemical Structure| 1211515-68-2

[ 1211515-68-2 ]

3-Bromo-5-methylpicolinic acid

Similarity: 0.94

Chemical Structure| 53636-56-9

[ 53636-56-9 ]

Methyl 3-bromo-2-pyridinecarboxylate

Similarity: 0.91

Chemical Structure| 61830-40-8

[ 61830-40-8 ]

3,5-Dibromopicolinic acid

Similarity: 0.91

Chemical Structure| 1133116-49-0

[ 1133116-49-0 ]

3,6-Dibromopicolinic acid

Similarity: 0.91

Chemical Structure| 1033201-61-4

[ 1033201-61-4 ]

6-Amino-3-bromopicolinic acid

Similarity: 0.91